A study to investigate whether adding a new hormone treatment for breast cancer, called Irosustat, to current hormone treatment (aromatase inhibitor) can affect the growth of breast cancer.
- Registry ID
- EUCTR2011-005680-25
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Imperial College London
- Start date
- 2012-04-24
- Completion date
- 2014-12-17
- Last update
- 2026-08-16
Conditions
- Locally advanced or metastatic breast cancer
Summary
To assess if adding Irosustat to existing aromatase inhibitor (AI) treatment in patients who have progressed on an AI can control cancer growth by either stopping its growth or reducing its size for a period of 6 months.
Locations
View on source registry